Asia Pacific Blood Glucose Monitoring Market Research Report Information, By Product Type, By Application, By End-User, And, By Region -Market Forecast till 2032

Description

List of Tables

Asia Pacific Blood Glucose Monitoring Market Research Report Information, By Product Type (Invasive Glucose Monitoring, Flash Glucose Monitoring, and CGM), By Application (Type 1 Diabetes, and Type 2 Diabetes), By End-User (Diagnostics Center, Hospitals, and Clinics), And, By Region (Asia-Pacific) -Market Forecast till 2032

Market Overview

In 2022, the Asia Pacific Blood Glucose Monitoring Market Size was estimated to be USD 1.1 billion. The Asia Pacific Blood Glucose Monitoring market industry is anticipated to experience a compound annual growth rate (CAGR) of 13.60% from USD 1.25 Billion in 2023 to USD 3.46 Billion by 2032 during the forecast period (2023-2032). The market's expansion is being driven by the increasing prevalence of diabetes and the increasing demand for reliable glucose monitoring equipment.

The Asia Pacific Blood Glucose Monitoring Market CAGR is being driven by the increasing prevalence of diabetes in the region. The prevalence rate of diabetes is approximately 8.5% in Asia-Pacific countries such as China and India, where the majority of individuals with the condition reside. To effectively diagnose and treat diabetes, devices that measure blood glucose are employed. The market is being stimulated by the rise in the number of diabetics who utilize blood glucose monitoring equipment. Obesity is considered one of the primary causes of the disease state, particularly type 2 diabetes. Furthermore, technical advancements and inventions facilitate the measurement of blood glucose levels. The market for glucose monitoring is typically propelled by the early detection of hypo- and hyperglycaemic situations, which are facilitated by these devices.

Market segment insights

The Asia Pacific Blood Glucose Monitoring market is segmented according to the product type into three categories: Invasive glucose monitoring, Flash Glucose Monitoring, and CGM.

Type 1 diabetes and Type 2 diabetes comprise the Asia Pacific Blood Glucose Monitoring market segmentation, as determined by its application.

Diagnostic centers, hospitals, and clinics comprise the Asia Pacific Blood Glucose Monitoring market segmentation, as determined by end-users.

Regional Perspectives

The study offers market insights into the Asia-Pacific region by region. The China Blood Glucose Monitoring market is anticipated to remain the dominant market throughout the forecasted period. Market demand has been stimulated by a substantial portion of the nation's patient population. The industry's expansion has been stimulated by the capacity to allocate additional funds toward disease control and treatment. The market will experience growth as a result of the expansion of businesses, increased consumer awareness, and improved product accessibility across the nation. Furthermore, the aging population of the nation is expected to increase industry demand, as senior individuals are more susceptible to developing type 2 diabetes. Furthermore, the expansion of businesses will be stimulated by government initiatives and campaigns that aim to increase awareness of diabetes management.

Major Players

Abbott Laboratories, Arkay Inc., Bayer Healthcare AG, F. Hoffmann-La Roche, Goldsite Diagnostics Inc., GlySure Ltd., Sphere Medical, Dexcom, LifeScan, and other prominent participants in the Asia Pacific Blood Glucose Monitoring Market.

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

3.1 OVERVIEW
3.2 DATA FLOW
- 3.2.1 DATA MINING PROCESS
3.3 PURCHASED DATABASE:
3.4 SECONDARY SOURCES:
- 3.4.1 SECONDARY RESEARCH DATA FLOW:
3.5 PRIMARY RESEARCH:
- 3.5.1 PRIMARY RESEARCH DATA FLOW:
3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
- 3.6.1 REVENUE ANALYSIS APPROACH
3.7 DATA FORECASTING
- 3.7.1 DATA FORECASTING TECHNIQUE
3.8 DATA MODELING
- 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
- 3.8.2 DATA MODELING:
3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

4.1 INTRODUCTION
4.2 DRIVERS
- 4.2.1 INCREASING INCIDENCES OF DIABETES ACROSS THE ASIA-PACIFIC
- 4.2.2 RISING AWARENESS AMONG INDIVIDUALS ABOUT THE BENEFITS OF BLOOD GLUCOSE MONITORING AND PATIENT EDUCATION
- 4.2.3 INCREASING GERIATRIC POPULATION
4.3 RESTRAINTS
- 4.3.1 HIGH COST OF BLOOD GLUCOSE MONITORING SYSTEMS
4.4 OPPORTUNITY
- 4.4.1 INCREASING GOVERNMENT INITIATIVES

5 MARKET FACTOR ANALYSIS

5.1 PORTER'S FIVE FORCES MODEL
- 5.1.1 THREAT OF NEW ENTRANTS
- 5.1.2 BARGAINING POWER OF SUPPLIERS
- 5.1.3 THREAT OF SUBSTITUTES
- 5.1.4 BARGAINING POWER OF BUYERS
- 5.1.5 INTENSITY OF RIVALRY
5.2 IMPACT OF COVID-19 ON THE ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET

6 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, BY PRODUCT

6.1 OVERVIEW
6.2 SELF-MONITORING DEVICES
- 6.2.1 BLOOD GLUCOSE METER
- 6.2.2 TESTING STRIPS
- 6.2.3 LANCETS
6.3 CONTINUOUS GLUCOSE MONITORING SYSTEMS
- 6.3.1 SENSORS
- 6.3.2 TRANSMITTER AND RECEIVERS

7 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, BY TESTING SITE

7.1 OVERVIEW
7.2 FINGERTIP SITE
7.3 ALTERNATE SITE

8 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, BY APPLICATION

8.1 OVERVIEW
8.2 TYPE 2 DIABETES
8.3 TYPE 1 DIABETES
8.4 GESTATIONAL DIABETES

9 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, BY END USER

9.1 OVERVIEW
9.2 HOSPITALS & CLINICS
9.3 HOMECARE SETTINGS

10 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, BY COUNTRY

10.1 OVERVIEW
- 10.1.1 AUSTRALIA
- 10.1.2 VIETNAM
- 10.1.3 MALAYSIA
- 10.1.4 INDONESIA
- 10.1.5 PHILIPPINES
- 10.1.6 THAILAND

11 COMPETITIVE LANDSCAPE

11.1 INTRODUCTION
11.2 MARKET SHARE ANALYSIS, 2022
11.3 COMPETITOR DASHBOARD
11.4 PUBLIC PLAYERS STOCK SUMMARY
11.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
- 11.6.1 COMPANY EXPANSION

12 COMPANY PROFILES

12.1 ASCENSIA DIABETES CARE HOLDINGS AG
- 12.1.1 COMPANY OVERVIEW
- 12.1.2 FINANCIAL OVERVIEW
- 12.1.3 PRODUCTS OFFERED
- 12.1.4 KEY DEVELOPMENTS
- 12.1.5 SWOT ANALYSIS
- 12.1.6 KEY STRATEGIES
12.2 B. BRAUN SE
- 12.2.1 COMPANY OVERVIEW
- 12.2.2 FINANCIAL OVERVIEW
- 12.2.3 PRODUCTS OFFERED
- 12.2.4 KEY DEVELOPMENTS
- 12.2.5 SWOT ANALYSIS
- 12.2.6 KEY STRATEGIES
12.3 SINOCARE
- 12.3.1 COMPANY OVERVIEW
- 12.3.2 FINANCIAL OVERVIEW
- 12.3.3 PRODUCTS OFFERED
- 12.3.4 KEY DEVELOPMENTS
- 12.3.5 KEY STRATEGIES
12.4 I-SENS, INC.
- 12.4.1 COMPANY OVERVIEW
- 12.4.2 FINANCIAL OVERVIEW
- 12.4.3 PRODUCTS OFFERED
- 12.4.4 KEY DEVELOPMENTS
- 12.4.5 KEY STRATEGY
12.5 TERUMO CORPORATION
- 12.5.1 COMPANY OVERVIEW
- 12.5.2 FINANCIAL OVERVIEW
- 12.5.3 PRODUCTS OFFERED
- 12.5.4 KEY DEVELOPMENTS
- 12.5.5 KEY STRATEGY
12.6 DEXCOM, INC
- 12.6.1 COMPANY OVERVIEW
- 12.6.2 FINANCIAL OVERVIEW
- 12.6.3 PRODUCTS OFFERED
- 12.6.4 KEY DEVELOPMENTS
- 12.6.5 KEY STRATEGIES
12.7 MEDTRONIC
- 12.7.1 COMPANY OVERVIEW
- 12.7.2 FINANCIAL OVERVIEW
- 12.7.3 PRODUCTS OFFERED
- 12.7.4 KEY DEVELOPMENTS
- 12.7.5 SWOT ANALYSIS
- 12.7.6 KEY STRATEGIES
12.8 ABBOTT
- 12.8.1 COMPANY OVERVIEW
- 12.8.2 FINANCIAL OVERVIEW
- 12.8.3 PRODUCTS OFFERED
- 12.8.4 KEY DEVELOPMENTS
- 12.8.5 SWOT ANALYSIS
- 12.8.6 KEY STRATEGIES
12.9 F. HOFFMANN-LA ROCHE LTD
- 12.9.1 COMPANY OVERVIEW
- 12.9.2 FINANCIAL OVERVIEW
- 12.9.3 PRODUCTS OFFERED
- 12.9.4 KEY DEVELOPMENTS
- 12.9.5 SWOT ANALYSIS
- 12.9.6 KEY STRATEGIES
12.10 YPSOMED HOLDING AG
- 12.10.1 COMPANY OVERVIEW
- 12.10.2 FINANCIAL OVERVIEW
- 12.10.3 PRODUCTS OFFERED
- 12.10.4 KEY DEVELOPMENTS
- 12.10.5 KEY STRATEGY

13 DATA CITATIONS

LIST OF TABLES

TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
TABLE 2 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 3 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, FOR SELF-MONITORING DEVICES, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 4 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, FOR SELF-MONITORING DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 5 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, FOR BLOOD GLUCOSE METER, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 6 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, FOR TESTING STRIPS, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 7 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, FOR LANCETS, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 8 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, FOR CONTINUOUS GLUCOSE MONITORING SYSTEMS, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 9 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, FOR CONTINUOUS GLUCOSE MONITORING SYSTEMS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 10 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, FOR SENSORS, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 11 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, FOR TRANSMITTER AND RECEIVERS, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 12 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, BY TESTING SITE, 2019-2032 (USD MILLION)
TABLE 13 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, FOR FINGERTIP SITE, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 14 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, FOR ALTERNATE SITE, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 15 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 16 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, FOR TYPE 2 DIABETES, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 17 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, FOR TYPE 1 DIABETES, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 18 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, FOR GESTATIONAL DIABETES, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 19 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 20 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, FOR HOSPITALS & CLINICS, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 21 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, FOR HOMECARE SETTINGS, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 22 ASIA-PACIFIC: BLOOD GLUCOSE MONITORING MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 23 ASIA-PACIFIC: BLOOD GLUCOSE MONITORING MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 24 ASIA-PACIFIC: BLOOD GLUCOSE MONITORING MARKET, FOR SELF-MONITORING DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 25 ASIA-PACIFIC: BLOOD GLUCOSE MONITORING MARKET, FOR CONTINUOUS GLUCOSE MONITORING SYSTEMS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 26 ASIA-PACIFIC: BLOOD GLUCOSE MONITORING MARKET, BY TESTING SITE, 2019-2032 (USD MILLION)
TABLE 27 ASIA-PACIFIC: BLOOD GLUCOSE MONITORING MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 28 ASIA-PACIFIC: BLOOD GLUCOSE MONITORING MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 29 AUSTRALIA: BLOOD GLUCOSE MONITORING MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 30 AUSTRALIA: BLOOD GLUCOSE MONITORING MARKET, FOR SELF-MONITORING DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 31 AUSTRALIA: BLOOD GLUCOSE MONITORING MARKET, FOR CONTINUOUS GLUCOSE MONITORING SYSTEMS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 32 AUSTRALIA: BLOOD GLUCOSE MONITORING MARKET, BY TESTING SITE, 2019-2032 (USD MILLION)
TABLE 33 AUSTRALIA: BLOOD GLUCOSE MONITORING MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 34 AUSTRALIA: BLOOD GLUCOSE MONITORING MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 35 VIETNAM: BLOOD GLUCOSE MONITORING MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 36 VIETNAM: BLOOD GLUCOSE MONITORING MARKET, FOR SELF-MONITORING DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 37 VIETNAM: BLOOD GLUCOSE MONITORING MARKET, FOR CONTINUOUS GLUCOSE MONITORING SYSTEMS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 38 VIETNAM: BLOOD GLUCOSE MONITORING MARKET, BY TESTING SITE, 2019-2032 (USD MILLION)
TABLE 39 VIETNAM: BLOOD GLUCOSE MONITORING MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 40 VIETNAM: BLOOD GLUCOSE MONITORING MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 41 MALAYSIA: BLOOD GLUCOSE MONITORING MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 42 MALAYSIA: BLOOD GLUCOSE MONITORING MARKET, FOR SELF-MONITORING DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 43 MALAYSIA: BLOOD GLUCOSE MONITORING MARKET, FOR CONTINUOUS GLUCOSE MONITORING SYSTEMS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 44 MALAYSIA: BLOOD GLUCOSE MONITORING MARKET, BY TESTING SITE, 2019-2032 (USD MILLION)
TABLE 45 MALAYSIA: BLOOD GLUCOSE MONITORING MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 46 MALAYSIA: BLOOD GLUCOSE MONITORING MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 47 INDONESIA: BLOOD GLUCOSE MONITORING MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 48 INDONESIA: BLOOD GLUCOSE MONITORING MARKET, FOR SELF-MONITORING DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 49 INDONESIA: BLOOD GLUCOSE MONITORING MARKET, FOR CONTINUOUS GLUCOSE MONITORING SYSTEMS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 50 INDONESIA: BLOOD GLUCOSE MONITORING MARKET, BY TESTING SITE, 2019-2032 (USD MILLION)
TABLE 51 INDONESIA: BLOOD GLUCOSE MONITORING MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 52 INDONESIA: BLOOD GLUCOSE MONITORING MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 53 PHILIPPINES: BLOOD GLUCOSE MONITORING MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 54 PHILIPPINES: BLOOD GLUCOSE MONITORING MARKET, FOR SELF-MONITORING DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 55 PHILIPPINES: BLOOD GLUCOSE MONITORING MARKET, FOR CONTINUOUS GLUCOSE MONITORING SYSTEMS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 56 PHILIPPINES: BLOOD GLUCOSE MONITORING MARKET, BY TESTING SITE, 2019-2032 (USD MILLION)
TABLE 57 PHILIPPINES: BLOOD GLUCOSE MONITORING MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 58 PHILIPPINES: BLOOD GLUCOSE MONITORING MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 59 THAILAND: BLOOD GLUCOSE MONITORING MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 60 THAILAND: BLOOD GLUCOSE MONITORING MARKET, FOR SELF-MONITORING DEVICES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 61 THAILAND: BLOOD GLUCOSE MONITORING MARKET, FOR CONTINUOUS GLUCOSE MONITORING SYSTEMS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 62 THAILAND: BLOOD GLUCOSE MONITORING MARKET, BY TESTING SITE, 2019-2032 (USD MILLION)
TABLE 63 THAILAND: BLOOD GLUCOSE MONITORING MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 64 THAILAND: BLOOD GLUCOSE MONITORING MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 65 PUBLIC PLAYERS STOCK SUMMARY
TABLE 66 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
TABLE 67 COMPANY EXPANSION
TABLE 68 ASCENSIA DIABETES CARE HOLDINGS AG: PRODUCTS OFFERED
TABLE 69 B. BRAUN SE: PRODUCTS OFFERED
TABLE 70 SINOCARE: PRODUCTS OFFERED
TABLE 71 I-SENS, INC.: PRODUCTS OFFERED
TABLE 72 TERUMO CORPORATION: PRODUCTS OFFERED
TABLE 73 DEXCOM, INC: PRODUCT OFFERED
TABLE 74 MEDTRONIC: PRODUCTS OFFERED
TABLE 75 ABBOTT: PRODUCTS OFFERED
TABLE 76 F. HOFFMANN-LA ROCHE LTD: PRODUCTS OFFERED
TABLE 77 YPSOMED HOLDING AG: PRODUCTS OFFERED

LIST OF FIGURES

FIGURE 1 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET: STRUCTURE
FIGURE 2 APAC BLOOD GLUCOSE MONITORING MARKET: MARKET GROWTH FACTOR ANALYSIS (2022-2032)
FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032)
FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET
FIGURE 6 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, PRODUCT SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION)
FIGURE 7 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, BY PRODUCT, 2022 & 2032 (USD MILLION)
FIGURE 8 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SHARE (%), BY PRODUCT, 2022
FIGURE 9 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, TESTING SITE SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION)
FIGURE 10 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, BY TESTING SITE, 2022 & 2032 (USD MILLION)
FIGURE 11 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SHARE (%), BY TESTING SITE, 2022
FIGURE 12 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION)
FIGURE 13 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, BY APPLICATION, 2022 & 2032 (USD MILLION)
FIGURE 14 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SHARE (%), BY GESTATIONAL DIABETES, 2022
FIGURE 15 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, END USER SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION)
FIGURE 16 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET, BY END USER, 2022 & 2032 (USD MILLION)
FIGURE 17 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SHARE (%), BY END USER, 2022
FIGURE 18 ASIA-PACIFIC MARKET ANALYSIS: BLOOD GLUCOSE MONITORING MARKET, 2019-2032 (USD MILLION)
FIGURE 19 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SHARE, BY COUNTRY, 2022 & 2032 (USD MILLION)
FIGURE 20 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SHARE, BY COUNTRY, 2022 (%)
FIGURE 21 ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET PLAYERS: COMPETITIVE ANALSIS, 2022
FIGURE 22 COMPETITOR DASHBOARD: ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET
FIGURE 23 ASCENSIA DIABETES CARE HOLDINGS AG: SWOT ANALYSIS
FIGURE 24 B. BRAUN SE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 B. BRAUN SE: SWOT ANALYSIS
FIGURE 26 I-SENS, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 TERUMO CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 DEXCOM, INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 MEDTRONIC: SWOT ANALYSIS
FIGURE 31 ABBOTT: FINANCIAL OVERVIEW
FIGURE 32 ABBOTT: SWOT ANALYSIS
FIGURE 33 F. HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 34 F. HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS
FIGURE 35 YPSOMED HOLDING AG: FINANCIAL OVERVIEW SNAPSHOT